Analysis of the Clinical Characteristics and Three Treatment Methods of Granulomatous Lobular Mastitis
Status: Recruiting
Location: See location...
Intervention Type: Procedure, Drug
Study Type: Observational
SUMMARY
Granulomatous lobular mastitis (GLM) is a rare benign breast disease that is difficult to distinguish from breast cancer based on clinical and imaging findings, and there is currently no standard treatment. This study aims to analyze the clinical characteristics and demographic data of GLM patients and to compare the overall effectiveness of three treatment methods: surgery alone, triple anti-tuberculosis drug therapy alone, and combined surgery with triple anti-tuberculosis drug therapy, with the goal of providing new insights for clinical treatment.
Eligibility
Participation Requirements
Sex: Female
Minimum Age: 15
Maximum Age: 65
View:
• non-lactating and aged 15-65 years
• histopathological confirmation of GLM
• normal liver and kidney function
Locations
Other Locations
China
First affiliated hospital of Harbin medical university
RECRUITING
Harbin
Contact Information
Primary
Yi Zhou
lubj2001@163.com
+86-0451-85552102
Time Frame
Start Date: 2024-08-19
Estimated Completion Date: 2024-10-19
Participants
Target number of participants: 350
Treatments
surgery group
The patients underwent surgery
triple anti-tuberculosis drug therapy group
The patients were treated with triple anti-tuberculosis drugs
combination therapy group
The patients were treated with surgery first, and then took triple anti-tuberculosis drugs after surgery
Related Therapeutic Areas
Sponsors
Leads: First Affiliated Hospital of Harbin Medical University